News
Why is the unique magic of tirzepatide highly sought after both domestically and internationally?
In recent years, the field of diabetes treatment has ushered in a "revolution" led by Tirzepatide. This innovative drug has attracted widespread attention due to its unique blood glucose control effect and significant weight loss benefits. Tilpoltide was approved by the US FDA in 2022 to assist in diet and exercise and help patients with type 2 diabetes control blood sugar. Since its launch, the drug has become a popular choice for many patients with diabetes because of its hot sales and market demand exceeding supply.
On a global scale, the discussion of Tirzepatide quickly spread on social media. From Reddit to Instagram, users are sharing their usage experience and discussing its effectiveness.
Unlike single target GLP-1 receptor agonists such as semaglutide, tilpotide is the first glucose dependent insulin-like peptide (GIP) and GLP-1 dual receptor agonist. In May 2022, Tirzepatide was approved by FDA, and its indication is to improve the blood sugar control of adult patients with type 2 diabetes through supplementary diet and exercise.
The unique magic of tilpotide
Excellent weight loss effects have been demonstrated in clinical trials, with Tirzepatide showing astonishing weight loss effects. For example, in the SURMUNT-1 study, participants in the 15mg dose group experienced an average weight loss of 20.9% after 72 weeks of treatment, which is currently the best weight loss data among GLP-1 drugs and almost equivalent to the effect of weight loss surgery.
Significant hypoglycemic effect
In addition to weight loss, Tirzepatide also shows outstanding performance in reducing blood sugar. As a therapeutic drug for diabetes, Tirzepatide can not only effectively reduce blood glucose levels, but also help reduce weight and cardiovascular events.
Dual action mechanism
Unlike other single target GLP-1 agonists such as semaglutide, tilpotide can simultaneously activate GIP and GLP-1 receptors. This dual mechanism makes it more effective in controlling blood sugar and weight.
Global market heat
Tirzepatide has received high attention worldwide, with drugs repeatedly sold out and in short supply, fully demonstrating its enormous market potential.
CATEGORIES
News
- Semaglutid was approved by the FDA for t2024-12-04
- Nourish the kidneys! semaglutide demonst2024-12-03
- semaglutide reduces the burden on the he2024-12-02
- Why is the unique magic of tirzepatide h2024-11-29
- Tirzepatide is a dual agonist of glucose2024-11-28
CONTACT US
Contact: NewPeptides
Phone: +852 6902 7583
E-mail: Linda@goodpeptides.com
Add: Science and Technology Industrial Park, Yuelu District, Changsha City, Hunan Province